Search

Search Constraints

You searched for: Author/Creator Case, Michael

Search Results

1. Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). (October 2019)

2. O1–06–04: Efficacy of solanezumab in patients with mild or moderate Alzheimer's disease: Pooled analyses findings from two phase III studies. (1st July 2013)

4. P2–164: Comparison of 11C‐PiB‐PET, FDG‐PET and MRI modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. (1st July 2013)

6. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Issue 2 (31st July 2015)

9. P3‐160: EMPIRICALLY DEFINING TRAJECTORIES OF LATE‐LIFE COGNITIVE AND FUNCTIONAL DECLINE. (1st July 2014)